Docetaxel, Cisplatin, and Trastuzumab As Primary Systemic Therapy for Human Epidermal Growth Factor Receptor 2–Positive Locally Advanced Breast Cancer
HURLEY, Judith, DOLINY, Philomena, REIS, Isildinha, SILVA, Orlando, GOMEZ-FERNANDEZ, Carmen, VELEZ, Pedro, PAULETTI, Giovanni, PEGRAM, Mark D, SLAMON, Dennis J
Published in Journal of clinical oncology (20.04.2006)
Published in Journal of clinical oncology (20.04.2006)
Get full text
Journal Article
Dose-dense docetaxel, carboplatinum and trastuzumab (ddTCH) as neoadjuvant therapy for human epidermal receptor 2 (HER2) positive breast cancer
Han, H. S., Doliny, P., Blaya, M., Gluck, S., Slingerland, J., Silva, O., Welsh, C., Hurley, J.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article
Split, low-dose docetaxel (D) and low-dose capecitabine (C) is an active regimen in metastatic breast cancer with minimal toxicity
Silva, O. E., Lopes, G., Morgensztern, D., Lobo, C., Abdullah, S., Doliny, P., Slingerland, J., Gluck, S., Santos, E., Welsh, C., Hurley, J.
Published in Journal of clinical oncology (20.06.2006)
Published in Journal of clinical oncology (20.06.2006)
Get full text
Journal Article
Breast Cancer and Human Immunodeficiency Virus: A Report of 20 Cases
Hurley, Judith, Franco, Sandra, Gomez-Fernandez, Carmen, Reis, Isildinha, Velez, Pedro, Doliny, Philomena, Harrington, William, Wilkinson, James, Kanhoush, Rima, Lee, Young
Published in Clinical breast cancer (01.10.2001)
Published in Clinical breast cancer (01.10.2001)
Get full text
Journal Article